Introduction: The International Academy of Cytology and the American Society of Cytopathology recently proposed the International System for Reporting Serous Fluid Cytology (ISRSFC) to standardize serous fluid cytopathology reporting and guide further clinical management. The current study aimed to assess the feasibility of utilizing ISRSFC reporting categories for serous fluids, estimate the risk of malignancy (ROM) of each category, and scrutinize if the management protocols followed in our institution are as per the ISRFSFC recommendations. Methods: All pleural, peritoneal, and pericardial effusions submitted for evaluation at our institute between January 2021 and December 2021 were retrieved. All these cases were reviewed and re-categorized into one of the five categories proposed by the ISRSFC: non-diagnostic (ND), negative for malignancy (NFM), atypia of uncertain significance (AUS), suspicious for malignancy (SFM), and malignant (MAL), and ROM was calculated for each category. Results: The present study examined 596 serous effusions, of which 229 were pleural effusions, 358 were peritoneal effusions, and the remaining nine were pericardial effusions. Among 596 cases, 395 cases had a radiological or histological follow-up. The serous effusion samples were re-categorized as 61 (10.2%) ND, 449 (75.3%) NFM, 47 (7.8%) AUS, 17 (2.9%) SFM, and 22 (3.8%) MAL, and ROM for each above category were 10%, 4.4%, 19%, 83.3%, and 100%, respectively. Conclusion: Categorizing serous effusion cytology samples per the ISRSFC diagnostic categories reduces reporting variability. The ISRSFC provides a standardized format to predict the ROM and thus improves the quality of clinical care.

Keywords:
The International System for Reporting Serous Fluid Cytology, Serous effusion, Cytopathology, Risk of malignancy, Management guidelines
1.
Michael CW. Serous fluid cytopathology: past, present, and future. Diagn Cytopathol. 2021;49(5):577–81.
2.
Pitman MB, Layfield LJ. Guidelines for pancreaticobiliary cytology from the Papanicolaou society of cytopathology: a review. Cancer Cytopathol. 2014;122(6):399–411.
3.
Nayar R, Wilbur D. The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes. Berlin/Heidelberg, Germany: Springer; 2015.
4.
Rosenthal DL, Wojcik EM, Kurtycz DFI. The Paris system for reporting urinary cytology. Berlin/Heidelberg, Germany: Springer; 2015.
5.
Layfield LJ, Baloch Z, Elsheikh T, Litzky L, Rektman N, Travis WD, et al. Standardized terminology and nomenclature for respiratory cytology: the Papanicolaou society of cytopathology guidelines. Diagn Cytopathol. 2016;44(5):399–409.
6.
Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341–6.
7.
Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini MP, Kurtycz DFI, et al. The milan system for reporting salivary gland cytopathology. Berlin/Heidelberg, Germany: Springer; 2018.
8.
Field AS, Raymond WA, Rickard M, Arnold L, Brachtel EF, Chaiwun B, et al. The international academy of cytology yokohama system for reporting breast fine-needle aspiration biopsy cytopathology. Acta Cytol. 2019;63(4):257–73.
9.
Chandra A, Crothers B, Kurtycz D, Schmitt F. Announcement: the international system for reporting serous fluid cytopathology. Acta Cytol. 2019;63(5):349–51.
10.
Crothers BA, Chandra A. Proceedings of the American Society of cytopathology companion session at the 2019 United States and Canadian Academy of Pathology meeting Part 1: towards an international system for reporting serous fluid cytopathology. J Am Soc Cytopathol. 2019;8(6):362–8.
11.
Chandra A, Crothers B, Iyama-Kurtycz D, Schmitt F. The international system for serous fluid cytopathology. Berlin/Heidelberg, Germany: Springer; 2020.
12.
Pinto D, Chandra A, Crothers BA, Kurtycz DFI, Schmitt F. The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management. J Am Soc Cytopathol. 2020;9(6):469–77.
13.
Sangisetty SL, Miner TJ. Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012;4(4):87–95.
14.
Lobo C, Costa J, Petronilho S, Monteiro P, Leça L, Schmitt F. Cytohistological correlation in serous effusions using the newly proposed international system for reporting serous fluid cytopathology: experience of an oncological center. Diagn Cytopathol. 2021;49(5):596–605.
15.
Rodriguez EF, Jones R, Gabrielson M, Santos D, Pastorello RG, Maleki Z. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on reporting pericardial effusion cytology. Acta Cytol. 2020;64(5):477–85.
16.
Hou T, Landon G, Stewart J, Roy-Chowdhuri S. The value of a tiered cytology diagnostic reporting system in assessing therisk of malignancy in indeterminate serous effusions. Cancer Cytopathol. 2021;129(1):75–82.
17.
Xu Y, Hu AY, Wang SM, Wang Q, Pan YC, Zhang SH. A retrospective analysis of pleural effusion specimens based on the newly proposed international system for reporting serous fluid cytopathology. Diagn Cytopathol. 2021;49(9):997–1007.
18.
Jha S, Sethy M, Adhya AK. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy. Diagn Cytopathol. 2021;49(10):1089–98.
19.
Kundu R, Srinivasan R, Dey P, Gupta N, Gupta P, Rohilla M, et al. Application of Indian academy of cytologists guidelines for reporting serous effusions: an institutional experience. J Cytol. 2021;38(1):1–7.
20.
Swiderek J, Morcos S, Donthireddy V, Surapaneni R, Jackson-Thompson V, Schultz L, et al. Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest. 2010;137(1):68–73.
21.
Thomas SC, Davidson LRR, McKean ME. An investigation of adequate volume for the diagnosis of malignancy in pleural fluids. Cytopathology. 2011;22(3):179–84.
22.
Rooper LM, Ali SZ, Olson MT. A minimum volume of more than 60 mL is necessary for adequate cytologic diagnosis of malignant pericardial effusions. Am J Clin Pathol. 2016;145(1):101–6.
23.
Pinto D, Cruz E, Branco D, Linares C, Carvalho C, Silva A, et al. Cytohistological correlation in pleural effusions based on the international system for reporting serous fluid cytopathology. Diagnostics. 2021;11(6):1126.
24.
Farahani SJ, Baloch Z. Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature. Diagn Cytopathol. 2019;47(11):1145–59.
© 2022 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2022
You do not currently have access to this content.